Showing results (181-190 of 379) with videos related to
Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIvelina Spassova, Selma Ugurel, Patrick Terheyden, et al.European Journal of Cancer (Oxford, England : 1990)|January 29, 2019
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanomaCaroline Robert, Keith Flaherty, Paul Nathan, et al.Annals of the Rheumatic Diseases|August 3, 2022
Distinct immune-effector and metabolic profile of CD8+ T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitorsKarolina Benesova, Franziska Viktoria Kraus, Rui A Carvalho, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 1, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centersNina Flatt, Corinna Kochanek, Yenny Angela, et al.Melanoma Research|November 14, 2023
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNISKatharina C Kähler, Dirk Debus, Gaston Schley, et al.Oncoimmunology|April 28, 2022
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)Jessica C Hassel, Timo E Schank, Heiko Smetak, et al.Plos One|November 22, 2013
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinomaKlaus G Griewank, Rajmohan Murali, Bastian Schilling, et al.Cancer Immunology, Immunotherapy : CII|April 18, 2019
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case seriesSelma Ugurel, Ivelina Spassova, Jonas Wohlfarth, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 20, 2026
Development and validation of the Essen Melanoma Quality of Life Inventory (EMQoLI)Venja Musche, Theresa Schadendorf, Adam Schweda, et al.European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.Pageof 38